Welcome to Prosperodes

Prosperodes will bring precision medicine for neurodegenerations within reach. Solutions for the early and accurate identification of different diseases are in great need. We will facilitate the development of patient-specific medicines, and the early assignment of personalized treatments.

We work with our partner company Phalanx GmbH ⇒ see PhalanxNeuro on a proprietary technology that mimics the "seeding" mechanism of protein aggregation that is associated with a wide range of neurodegenerative diseases. This include Alzheimer's disease, Parkinson's disease, Lewy body dementia, fronto-temporal dementia and amyotrophic lateral sclerosis.

About us

The founders, Dr. Christiane Ritter, Dr. Thorsten Lührs and Arne Ungruh (LL. M.) have a long-standing expertise in neurodegeneration associated seeding processes, medical device development and business development.

With a very experienced interdisciplinary team and strong partners, Prosperodes is rapidly building the company to become a major player in aging related diseases.

Are you self-motivated and interested in working with a knowledge driven team in a dynamic and inspiring environment? Do you want to make a real difference in the lives of people? We are always looking for dedicated talents to join our mission and strengthen our team in the areas of research & product development, clinical development and marketing & sales.

© 2023 Prosperodes GmbH – info